title: Aged Tgfbeta2/Gdnf double-heterozygous mice show no morphological and functional alterations in the nigrostriatal system.
abstract: Loss of dopaminergic neurons in the substantia nigra pars compacta and the resulting decrease in striatal dopamine levels are the hallmarks of Parkinson's disease. Tgfbeta and Gdnf have been identified as neurotrophic factors for dopaminergic midbrain neurons in vivo and in vitro. Haploinsufficiency for either Tgfbeta or Gdnf led to dopaminergic deficits. In this study we therefore analyzed the nigrostriatal system of aged Tgfbeta2 (+/-)/Gdnf (+/-) double-heterozygous mice. Unexpectedly, we found no morphological changes in the nigrostriatal system as compared with age-matched wild-type mice. There were no significant differences in the number of TH-positive midbrain neurons and no changes in the optical density of TH immunoreactivity in striata of Tgfbeta2 (+/-)/Gdnf (+/-) double-heterozygous mice. Moreover, we found no significant differences in the striatal levels of dopamine and its metabolites dihydroxyphenylacetic acid and homovanillic acid. Our results indicate that a combined haploinsufficiency for Tgfbeta2 and Gdnf has no impact on the function and the survival of midbrain DA neurons under normal aging conditions.
authors.affiliation: Department of Molecular Embryology, Institute of Anatomy and Cell Biology, Albert-Ludwigs-University Freiburg, Freiburg, Germany. stephan.heermann@zoo.uni-heidelberg.de
authors.forename: Stephan
authors.initials: S
authors.lastname: Heermann
authors.forename: Felipe
authors.initials: F
authors.lastname: Opazo
authors.forename: Björn
authors.initials: B
authors.lastname: Falkenburger
authors.forename: Kerstin
authors.initials: K
authors.lastname: Krieglstein
authors.forename: Björn
authors.initials: B
authors.lastname: Spittau
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000375:Aging; D000704:Analysis of Variance; D000818:Animals; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003342:Corpus Striatum / Q000473:pathology*; D004298:Dopamine / Q000378:metabolism; D004563:Electrochemistry / Q000379:methods; D005786:Gene Expression Regulation / Q000235:genetics*; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000172:deficiency / Q000235:genetics*; D006719:Homovanillic Acid / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009434:Neural Pathways / Q000473:pathology; D012333:RNA, Messenger / Q000378:metabolism; D013378:Substantia Nigra / Q000473:pathology*; D053781:Transforming Growth Factor beta2 / Q000172:deficiency / Q000235:genetics*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: C495040:Gdnf protein, mouse; D051100:Glial Cell Line-Derived Neurotrophic Factor; D012333:RNA, Messenger; C509042:Tgfb2 protein, mouse; D053781:Transforming Growth Factor beta2; D015102:3,4-Dihydroxyphenylacetic Acid; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine; D006719:Homovanillic Acid
references.citation: J Neurosci. 2006 Oct 25;26(43):11230-8
references.pmid: 17065462
references.citation: Neuroscience. 1994 Dec;63(4):1189-96
references.pmid: 7700516
references.citation: PLoS Biol. 2007 Mar;5(3):e39
references.pmid: 17298183
references.citation: EMBO J. 1995 Feb 15;14(4):736-42
references.pmid: 7882977
references.citation: J Comp Neurol. 1995 May 15;355(4):479-89
references.pmid: 7636027
references.citation: J Neurosci. 2003 Jun 15;23(12):5178-86
references.pmid: 12832542
references.citation: Int J Dev Neurosci. 2009 Feb;27(1):97-102
references.pmid: 18824086
references.citation: Brain Res. 1995 Feb 20;672(1-2):104-11
references.pmid: 7749731
references.citation: J Neurosci. 1998 Dec 1;18(23):9822-34
references.pmid: 9822741
references.citation: Neurobiol Dis. 2007 Feb;25(2):378-91
references.pmid: 17141511
references.citation: J Cell Biol. 2002 Oct 14;159(1):157-67
references.pmid: 12370242
references.citation: Neurobiol Dis. 2006 Mar;21(3):568-75
references.pmid: 16257223
references.citation: Neuron. 2003 Sep 11;39(6):889-909
references.pmid: 12971891
references.citation: Nature. 1995 Jan 26;373(6512):335-9
references.pmid: 7830766
references.citation: J Histochem Cytochem. 1981 Jun;29(6):775
references.pmid: 7252134
references.citation: Science. 1993 May 21;260(5111):1130-2
references.pmid: 8493557
references.citation: Development. 1997 Jul;124(13):2659-70
references.pmid: 9217007
references.citation: Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8935-9
references.pmid: 7568047
references.citation: Nature. 1996 Jul 4;382(6586):73-6
references.pmid: 8657307
references.citation: Science. 2000 Oct 27;290(5492):767-73
references.pmid: 11052933
references.citation: Exp Neurol. 2006 Dec;202(2):336-47
references.pmid: 16889771
references.citation: Stem Cells. 2008 Jul;26(7):1683-94
references.pmid: 18420832
references.citation: Neurosci Lett. 1994 Nov 21;182(1):107-11
references.pmid: 7891873
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20049-54
references.pmid: 18056810
references.citation: APMIS. 1988 Oct;96(10):857-81
references.pmid: 3056461
references.citation: Nature. 1996 Jul 4;382(6586):70-3
references.pmid: 8657306